ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,324,689 | -12.2% | 180,234 | +0.0% | 0.27% | -17.4% |
| Q4 2022 | $22,011,124 | +72.8% | 180,227 | +46.1% | 0.33% | +69.9% |
| Q3 2022 | $12,736,000 | -0.4% | 123,340 | -10.3% | 0.19% | -6.8% |
| Q2 2022 | $12,783,000 | -15.8% | 137,510 | +6.3% | 0.21% | +11.3% |
| Q1 2022 | $15,178,000 | +38.9% | 129,325 | +59.2% | 0.19% | +66.1% |
| Q4 2021 | $10,930,000 | -15.5% | 81,246 | +0.1% | 0.11% | -26.8% |
| Q3 2021 | $12,934,000 | +74.9% | 81,147 | +44.3% | 0.15% | +56.1% |
| Q2 2021 | $7,397,000 | +9.6% | 56,233 | +7.3% | 0.10% | -2.0% |
| Q1 2021 | $6,752,000 | -78.0% | 52,389 | -71.6% | 0.10% | -79.9% |
| Q4 2020 | $30,741,000 | +20.7% | 184,320 | +11.6% | 0.50% | -5.0% |
| Q3 2020 | $25,478,000 | -7.5% | 165,101 | -11.4% | 0.52% | -21.9% |
| Q2 2020 | $27,555,000 | +48.1% | 186,307 | +12.7% | 0.67% | +7.7% |
| Q1 2020 | $18,608,000 | -13.9% | 165,244 | +6.3% | 0.62% | +8.2% |
| Q4 2019 | $21,621,000 | +57.4% | 155,412 | +9.0% | 0.58% | +28.6% |
| Q3 2019 | $13,736,000 | -16.8% | 142,605 | -0.5% | 0.45% | -13.5% |
| Q2 2019 | $16,505,000 | -17.9% | 143,331 | -16.1% | 0.52% | -31.5% |
| Q1 2019 | $20,111,000 | +1163.3% | 170,865 | +572.3% | 0.76% | +1010.3% |
| Q4 2018 | $1,592,000 | -55.0% | 25,414 | -49.1% | 0.07% | -37.6% |
| Q3 2018 | $3,536,000 | +34.2% | 49,906 | +26.0% | 0.11% | +22.5% |
| Q2 2018 | $2,634,000 | -17.8% | 39,593 | -19.2% | 0.09% | -21.2% |
| Q1 2018 | $3,206,000 | -11.0% | 49,021 | -50.6% | 0.11% | -19.3% |
| Q3 2017 | $3,601,000 | – | 99,328 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |